3 treatment centers
Malibu Recovery Center
Malibu, California
Milestones
Malibu, California
Passages Malibu
Malibu, California
No centers match
Try a different search term
3 SAMHSA-listed treatment centers in Malibu, California. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Malibu, California
Malibu, California
Malibu, California
Try a different search term
Malibu, California has 3 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. California faces a severe fentanyl and methamphetamine crisis, with over 10,000 overdose deaths annually.
Available programs in Malibu include 2 residential/inpatient rehab programs, 1 outpatient program, 2 dual diagnosis (co-occurring mental health) programs, and 1 medical detox facility. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Malibu accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 3 treatment options in Malibu, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Malibu.
Treatment centers in Malibu accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Family members of Malibu patients in active addiction can access support through Al-Anon, Nar-Anon, SMART Recovery Family & Friends, and Community Reinforcement and Family Training (CRAFT). CRAFT specifically teaches evidence-based techniques for engaging a reluctant family member into treatment — research shows approximately 70% of CRAFT participants successfully engage their loved one into treatment within 3-6 months, substantially higher than traditional intervention approaches.
Severe mental illness — schizophrenia, schizoaffective disorder, severe bipolar — requires specialized clinical capacity that not every Malibu addiction-treatment program maintains. Patients with active psychotic symptoms, recent psychiatric hospitalization, or complex psychiatric medication regimens may need facilities with on-site psychiatric providers, integrated mental-health-and-addiction protocols, and connections to outpatient psychiatric continuity. Admissions screening should explicitly address this fit before the patient commits.
The addiction-treatment landscape in Malibu, California, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Malibu providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
Pre-authorization is the most common insurance friction for Malibu patients entering residential addiction treatment. Insurers require clinical documentation that ASAM criteria for residential placement are met — specifically that lower-intensity outpatient care has been tried or is clinically insufficient, and that the patient's withdrawal risk, co-occurring conditions, or environmental factors require 24-hour structure. Treatment-provider clinical staff handle this documentation; patients can typically expect 24-48 hour authorization turnaround.
Documentation and consent at Malibu program admission is structured to comply with 42 CFR Part 2 confidentiality of substance-use treatment records — a heightened standard above HIPAA. Patients typically sign multiple consent forms: treatment consent, releases for specific communications (with family, employer, legal contacts, other providers), and acknowledgments of program policies. These consents are revocable and patients retain control over disclosure of their treatment information except for narrow regulatory exceptions.
Long-term medication management for Malibu patients in recovery often extends well beyond program completion: MAT for opioid use disorder typically continues for years (or indefinitely) and is associated with sustained mortality reduction; naltrexone for alcohol use disorder is typically a 6-12 month course; psychiatric medications continue per indication regardless of recovery status. Outpatient prescribers in Malibu familiar with addiction recovery patient populations provide continuity that general primary care often can't replicate.
Withdrawal severity is the first clinical screening factor for treatment entry in Malibu. Patients showing or at risk for moderate-to-severe alcohol or benzodiazepine withdrawal typically require medically managed detox before transitioning to lower-intensity care — untreated severe alcohol withdrawal carries 5% mortality and severe benzodiazepine withdrawal can be fatal. Opioid use patients face a different pathway: detox-only is rarely effective for opioid use disorder, and evidence-based protocols typically initiate medication-assisted treatment (buprenorphine or methadone) during the stabilization phase.